DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹7,734 Cr | ₹4,677 Cr | ₹2,002 Cr | ₹1,347 Cr | ₹3,385 Cr |
What is the latest Total Debt ratio of DR REDDYS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹7,734 Cr |
| Mar2025 | ₹4,677 Cr |
| Mar2024 | ₹2,002 Cr |
| Mar2023 | ₹1,347 Cr |
| Mar2022 | ₹3,385 Cr |
How is Total Debt of DR REDDYS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,734 Cr | 65.38 | |
| Mar2025 | ₹4,677 Cr | 133.60 | |
| Mar2024 | ₹2,002 Cr | 48.60 | |
| Mar2023 | ₹1,347 Cr | -60.20 | |
| Mar2022 | ₹3,385 Cr | - | |
Compare Total Debt of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹112,997.5 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| MANKIND PHARMA | ₹104,550.0 Cr | 1.7% | 8.3% | 9.4% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1.1% |
5.9% |
6.6% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses